The Association of MUC16 Mutation with Tumor Mutation Burden and Its Prognostic Implications in Cutaneous Melanoma.
Xuefeng WangXiaoqing YuMichael KrauthammerWilly HugoChunzhe DuanPeter A KanetskyJamie K TeerZachary J ThompsonDenise KalosKenneth Y TsaiKeiran S M SmalleyVernon K SondakY Ann ChenJose R Conejo-GarciaPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)
This is, to the best of our knowledge, the first systematic evaluation of MUC16 mutation as a clinical biomarker and a predictive biomarker for immunotherapy in melanoma.
Keyphrases